Department of Infectious Diseases, Beijing Jishuitan Hospital, NO.68, Huinan North Road, Changping District, Beijing City, 100096, China.
Department of Pulmonary and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao City, Shandong Province, China.
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620953780. doi: 10.1177/1753466620953780.
Respiratory viruses are important etiologies of community-acquired pneumonia. However, current knowledge on the prognosis of respiratory virus-related pneumonia (RV-p) is limited. Thus, here we aimed to establish a clinical predictive model for mortality of patients with RV-p.
A total of 1431 laboratory-confirmed patients with RV-p, including 1169 and 262 patients from respective derivation and validation cohorts from five teaching hospitals in China were assessed between January 2010 and December 2019. A prediction rule was established on the basis of risk factors for 30-day mortality of patients with RV-p from the derivation cohort using a multivariate logistic regression model.
The 30-day mortality of patients with RV-p was 16.8% (241/1431). The RV-p score was composed of nine predictors (including respective points of mortality risk): (a) age ⩾65 years (1 point); (b) chronic obstructive pulmonary disease (1 point); (c) mental confusion (1 point); (d) blood urea nitrogen (1 point); (e) cardiovascular disease (2 points); (f) smoking history (2 points); (g) arterial pressure of oxygen/fraction of inspiration oxygen (PO/FiO) < 250 mmHg (2 points); (h) lymphocyte counts <0.8 × 10/L (2 points); (i) arterial PH < 7.35 (3 points). A total of six points was used as the cut-off value for mortality risk stratification. Our model showed a sensitivity of 0.831 and a specificity of 0.783. The area under the receiver operating characteristic curve was more prominent for RV-p scoring [0.867, 95% confidence interval (CI)0.846-0.886] when compared with both pneumonia severity index risk (0.595, 95% CI 0.566-0.624, < 0.001) and CURB-65 scoring (0.739, 95% CI 0.713-0.765, < 0.001).
RV-p scoring was able to provide a good predictive accuracy for 30-day mortality, which accounted for a more effective stratification of patients with RV-p into relevant risk categories and, consequently, help physicians to make more rational clinical decisions.The reviews of this paper are available via the supplemental material section.
呼吸道病毒是社区获得性肺炎的重要病因。然而,目前关于呼吸道病毒相关性肺炎(RV-p)预后的知识有限。因此,本研究旨在建立一个预测 RV-p 患者死亡率的临床预测模型。
本研究纳入了 2010 年 1 月至 2019 年 12 月期间来自中国五所教学医院的各自为 1169 例和 262 例的两个验证队列的 1431 例经实验室确诊的 RV-p 患者。使用多变量逻辑回归模型,基于 RV-p 患者 30 天死亡率的风险因素,在推导队列中建立预测规则。
RV-p 患者的 30 天死亡率为 16.8%(241/1431)。RV-p 评分由九个预测因子(各有相应的死亡风险分数)组成:(a)年龄 ⩾65 岁(1 分);(b)慢性阻塞性肺疾病(1 分);(c)精神错乱(1 分);(d)血尿素氮(1 分);(e)心血管疾病(2 分);(f)吸烟史(2 分);(g)动脉血氧分压/吸入氧分数(PO/FiO) ⩽250mmHg(2 分);(h)淋巴细胞计数 ⩽0.8×10/L(2 分);(i)动脉 pH ⩽7.35(3 分)。总分 6 分作为死亡风险分层的截断值。我们的模型显示出 0.831 的敏感性和 0.783 的特异性。与肺炎严重指数风险(0.595,95%CI 0.566-0.624,<0.001)和 CURB-65 评分(0.739,95%CI 0.713-0.765,<0.001)相比,RV-p 评分在接受者操作特征曲线下面积方面更为显著[0.867,95%CI 0.846-0.886]。
RV-p 评分能够为 30 天死亡率提供良好的预测准确性,能够将 RV-p 患者更有效地分为相关风险类别,从而帮助医生做出更合理的临床决策。本文的评审意见可通过补充材料部分查看。